Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
TOLREMO therapeutics Completes USD 39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest
Life Sciences Times
-
September 20, 2023
0
Venture Capital
SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough Medicines
Life Sciences Times
-
September 20, 2023
0
Venture Capital
Virtual Incision Extends Series C Round with Additional $30M Funding
Life Sciences Times
-
September 19, 2023
0
Venture Capital
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
Life Sciences Times
-
September 19, 2023
0
Venture Capital
BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
Life Sciences Times
-
September 19, 2023
0
Venture Capital
ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension to Support Advancement of Lead Program into Clinical Development for Autoimmune Disease
Life Sciences Times
-
September 12, 2023
0
Venture Capital
LabShares Acquired by Life Sciences Industry Veteran Philip Borden and Pacific Lake Partners
Life Sciences Times
-
September 12, 2023
0
Venture Capital
Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials
Life Sciences Times
-
September 7, 2023
0
Venture Capital
Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million
Life Sciences Times
-
September 6, 2023
0
Venture Capital
Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital
Life Sciences Times
-
September 6, 2023
0
Venture Capital
TeleVet Announces $43 Million Series B on the Heels of Record Growth, Rebrands as Otto
Life Sciences Times
-
August 31, 2023
0
Venture Capital
QuantHealth Announces $15M Series A for its AI Platform That Enhances Success of Clinical Trials
Life Sciences Times
-
August 30, 2023
0
1
...
41
42
43
...
115
Page 42 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026